elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40640808-C56E74C5-C031-433C-83AA-C77C2F7D08ED
Q40640808-C56E74C5-C031-433C-83AA-C77C2F7D08ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40640808-C56E74C5-C031-433C-83AA-C77C2F7D08ED
PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer.
P2860
Q40640808-C56E74C5-C031-433C-83AA-C77C2F7D08ED
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40640808-C56E74C5-C031-433C-83AA-C77C2F7D08ED
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
777327366aa8b41ab2f4fddb5bb44c925349b285
P2860
SLFN11 inhibits checkpoint maintenance and homologous recombination repair.